Hair restoration sits at an unusual intersection of dermatology, surgery, and regenerative medicine. For most of the past two decades the category attracted limited industry attention in India, growing in pockets rather than as a structured specialty. That has changed. The discipline has matured into a recognisable healthcare segment with consolidating clinical standards, identifiable centres of excellence, and a…
Shots:
PrimeGen US has entered into a definitive business combination agreement with DT Cloud Star at an implied equity value of ~$1.5B, with closing expected in H2’26
After closing, the combined entity is expected to operate as PrimeGen US or a successor company & will be listed on Nasdaq under a new ticker symbol
PrimeGen…
Shots:
With the healthcare sector moving ahead with its technological advances, there is still an unexplored section in therapeutics that requires much more attention. Through innovations, life science companies have evolved to make breakthrough discoveries in many focus areas, but when it comes to the rare disease segment, all our endeavors seem to be bleak…

